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Abstract
Background: Liver Retransplantation (Re-LT) procedures are associated with an increased risk of morbidity and
mortality. Up to date, there is no knowledge on the health-related quality of life and the mental status of these
patients.
Methods: Health-Related Quality of Life (HRQoL) was assessed by using the Short Form 36 (SF-36) Health Survey
and Mental Status was assessed by using the Hospital Anxiety and Depression Scale (HADS). The patients were
examined in different assessments: During regular check-up examinations in the LT outpatient department in 2011
(Survey 1) and in a postal survey in 2013 (Survey 2). Their medical data was collected by using an established database.
Results: We received eligible surveys of 383 patients (55.6%) with a history of LT, of which 15 (3.9%) had undergone
Re-LT (Re-LT group). These patients were compared to a group of 60 patients who had undergone only one LT. With
regard to their HRQoL, the Re-LT group had significantly lower scores on the scales of physical function (PF, p = 0.026),
their role-physical (RP, p = 0.008), their vitality (VIT, p = 0.040), and their role-emotional (RE, p = 0.005). The scores for
anxiety and depression did not differ significantly between the groups. In a multiple regression analysis, chronic kidney
disease was found to be an independent risk factor for decreased scores of PF (p = 0.023).
Conclusions: Patients who have to undergo Re-LT procedures are faceing impairments in physical aspects of a HRQoL.
Together with clinical results from other studies, the findings of the present examination underline the need for an
optimized organ distribution strategy since not all patients listed for Re-LT appear to benefit from it.
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Background
Orthotopic Liver Transplantation (LT) is the only curative
treatment for an end-stage liver disease (ESLD), as well as
for an acute liver failure (ALF) and a non-resectable hepa-
tocellular carcinoma. This well-established procedure has
acceptable long-term outcomes with the overall survival
of patients at 71% after 5 years. Nonetheless, graft survival
is lower at 64% [1]. Thus, a considerable proportion of
patients need to undergo an orthotopic Liver Retrans-
plantation (Re-LT) after their first LT. Today, around
10% of all LT procedures are Re-LTs. Indications for an
Re-LT are mostly due to primary nonfunction, venous
thrombosis (early graft failure), ischemic type biliary
lesions (ITBL) and a recurrence of the initial disease
(late graft failure) [2, 3]. For improvements in the over-
all survival rates raises the likelihood for an Re-LT, as it
increases the risks for a chronic graft failure or a recur-
rence of the primary disease [4, 5].
One of the major problems of Re-LT is the fact that the
outcome of these patients is significantly decreased with
significantly higher complication and hospitalisation rates
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compared to recipients of primary LT although Re-LT re-
cipients often benefit from organs with a lower Donor
Risk Index. Thus, it is suggested by some authors that a
more optimal strategy of distributing organs should be
established. This strategy should include restricting their
use to patients who obtain a longer term benefit [6].
Besides a mere graft and patient survival, both the
Health-Related Quality of Life (HRQoL) and the Mental
Status have become an issue of further interest, as they
are important outcome factors [7–10]. It is well-known
that transplantation improves the HRQoL, as well as the
mental status, when compared to those patients on an
LT waiting list [7, 11]. However, there are currently only
a few examinations that have focused on these particular
outcome variables among Re-LT recipients [9, 12–14].
Since Re-LT is associated with an increased postopera-
tive morbidity and a prolonged or insufficient recovery
when compared to a primary LT, an impairment of the
mental well-being and the HRQoL can be supposed [15].
Thus, the current study has sought to evaluate the
HRQoL and the mental status of Re-LT recipients when
compared to patients with a history of only one LT. Fur-
thermore, the study aimed to investigate predictors that




The design of the present study is cross-sectional. It was
conducted at the University Hospital of Leipzig, in the
Department of Visceral, Transplantation, Thoracic and
Vascular Surgery, Germany. It was approved by the
Local Ethics Committee (ID: 414–12-17,122,012). All of
the surviving patients who had received an LT between
1989 and 2013 were identified. In a second step, those
recipients of a double transplant (sequential or simultan-
eous liver and kidney transplants) and a liverretransplan-
tation were identified.
The patients were recruited in two different assess-
ments. One assessment was performed in 2011. Patients
were asked to complete both a written SF-36 health sur-
vey and a HADS survey during regular check-up exami-
nations in the LT outpatient department (Survey 1). The
second assessment was performed as a postal survey in
2013. Patients received the two surveys, including return
envelopes, free of charge, via the mail (Survey 2). In this
second assessment, patients were asked to complete the
questionnaires within 2 weeks. Those patients who did
not answer the first mail were contacted a second time
after 2 weeks. They were reminded and asked again to
return the questionnaires within another 14 days. The
response rate in this second postal survey was 40% [16].
The German version of both questionnaires was used.
The data from both assessments were collected in one
database.
Patients
The inclusion criteria were as follows:
– age > 18 years
– a questionnaire with at least 50% of the questions
answered
– their medical records were available
From all of the patients who returned a complete sur-
vey, those patients with a history of Re-LT were selected.
From the remaining patients with primary LT, a second
group was created. The patients were 1:4 matched ac-
cording to their variables of age and gender. The follow-
ing two groups were available for further analyses:
– Re-LT recipients (Re-LT group)
– Patients with a history of only one Liver
Transplantation (LT-group)
Besides the collection of data on their mental status
and their HRQoL, various clinical and demographic vari-
ables were included in their analyses. The assessment of
comorbidities included arterial hypertension (AH), dia-
betes mellitus (DM) and chronic kidney failure (CKF).
CKF was determined as being a non-reversible reduction
of the glomerular filtration rate < 90 ml/min/1.73 m2,
representing a CKF Stage 2 or higher, as defined by the
“Kidney Disease Improving Global Outcomes” (KDIGO)
[17]. There was no patient with a dialysis-dependent
end-stage renal failure.
Short form-36 (SF-36)
The SF-36 questionnaire comprises of 36 questions on
an individual’s current health status [18]. It is an assess-
ment instrument for the HRQoL of people aged 14 and
beyond.
In total, there are 8 different dimensions of HRQoL,
which are summarized into two main scales: the physical
component summary (PCS) and the mental component
summary (MCS).
The 8 dimensions include physical functioning (PF, 10
items), role-physical (RP, 4 items), bodily pain (BP, 2
items), general health perceptions (GH, 6 items), vitality
(VIT, 4 items), social functioning (SF, 2 items), role-
emotional (RE, 3 items), and mental health (MH, 5
items). The range of possible scores in each subscale is
between 0 and 100 points [18, 19].
Hospital anxiety and depression scale (HADS)
The HADS survey is a tool that is used in order to
screen for depression and anxiety. It is a well-established
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and validated survey that is widely used in the field of
medicine [20]. In the present study, we used the German
version of the survey, according to Herrmann and col-
leagues [21].
The questionnaire consists of 14 questions: 7 ques-
tions for the assessment of anxiety and 7 questions for
the assessment of depression. There are 4 possible
multiple-choice answers for each item with a corre-
sponding score of 0 to 3. As a result, the maximum
score for each dimension (anxiety and depression, re-
spectively) is 21. A score of 0 to 7 means a normal test
result, scores of between 8 to 10 points indicate mild
symptoms, and a score of 10 or higher is defined as se-
vere symptoms [22].
Statistical analyses
The data was collected when using Microsoft Excel
(Microsoft, Redmond, USA). A statistics program (SPSS
20.0, IBM, Armonk, USA) was used for the statistical
analyses. Before importing the data into the SPSS, all of
the questionnaires were digitised and computed (EvaSys©
system, Electric Paper Evaluations Systeme GmbH,
Lüneburg, Germany).
The continuous variables were analysed by using non-
parametric statistical tests (Kruskal-Wallis test, the
Mann-Whitney U test and Wilcoxon test). The categor-
ical variables were tested by using the Fisher’s exact test.
Multiple regression analysis was performed using a lin-
ear regression model. All p-values <0.05 were indicated
as being of a statistical significance.
Note: This study has partially analysed data of a large
cross-sectional study of transplant candidates and
transplant recipients. In parts, it has been previously
published [7, 8, 23, 24]. However, these publications
considered different inclusion criteria and used a
different patient subset (e.g. waitlisted patient vs.
transplant recipients). In this present analysis, we have
reported on the recipients of a Liver retransplantation
for the first time. Moreover, the current study has
included a second set of patients that were examined
earlier (in 2011). So far, this data is unpublished.
Results
Baseline characteristics
The number of surviving patients who had received an
LT was 689. We received eligible surveys from 383 pa-
tients (55.6%). Of these 383 patients, 106 (27.7%) were
interviewed during Survey 1 and 117 (30.5%) were inter-
viewed during Survey 2. The remaining 160 patients
(41.8%) were interviewed twice (in 2011 and in 2013, re-
spectively). For these cases, results from both surveys
were statistically compared. The results are shown in
Fig. 1. For the following comparison between Re-LT and
LT patients, only the most recent survey was used.
When the second survey was performed in 2013, the rel-
atives of 27 patients informed us that the patient had de-
ceased in the meantime.
Fifteen patients with a history of Re-LT could be iden-
tified (Re-LT group). There were 7 male (46.7%) and 8
female patients (53.3%) with a mean age of 53.6 years
(standard deviation, SD = 8.4, range 31–66). The
matched LT group (n = 60) consisted of 28 male (46.7%)
and 32 female patients (53.3%), with a mean age of
53.5 years (SD = 8.8, range 24–66).
Of these 75 patients, 19 (25.3%) were interviewed dur-
ing Survey 1 (in 2011), 33 (44%) were interviewed during
both Survey 1 and Survey 2, and 23 (30.7%) were inter-
viewed during Survey 2 in 2013.
Between both of the groups, there were no significant
differences of the variables concerning gender, age, an
underlying disease, religiousness, family status, relation-
ship status, comorbidities, and the time elapsed since
the transplantation (Re-LT group: last transplantation)
(all p > 0.05, Table 1).
SF-36 results
The HRQoL scores were lower in all 8 dimensions, as
well as in the summation scales of PCS and MCS,
among the Re-LT group when compared to the LT
group. Statistically significant differences were found for
PF (p = 0.026), RP (p = 0.008), VIT (p = 0.040), and RE
(p = 0.005). Figure 2 shows the SF-36 results.
HADS results
The highest values were found in the Re-LT group for
anxiety, depression, and the totals of the HADS scores.
The differences were not statistically significant
(p = 0.310, 0.123 and 0.213, Fig. 3).
Impact of the clinical and demographical variables on the
mental status and the HRQoL
In a second step, the impact of the comorbidities (chronic
kidney disease, arterial hypertension, diabetes mellitus) as
well as demographical factors such as age (<55 and
≥55 years, respectively) and gender on the HRQoL (Table 2)
and mental status (Table 3) was assessed in a univariate ana-
lyis. With regard to the HADS scores and SF-36 scores in
the Re-LT group and the LT group, the factors arterial
hypertension, diabetes mellitus, gender and age did not have
a significant impact (all p > 0.05). Those patients who suf-
fered from a chronic kidney disease had decreased scores
for PF when compared to the patients with a normal kidney
function (p = 0.011, Table 2). In a multiple regression ana-
lysis on all HADS and SF-36 dimensions, chronic kidney
disease was found to be the only independent risk factor for
reduced PF scores (Correlation coefficient B = −0.279,
t = −2.319, p = 0.023). All other variables did not show
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significances in the multiple regression analysis (all p-values
>0.05).
Discussion
The present study has shown that the Re-LT patients
had significantly impaired HRQoL scores, with regards
to their physical dimensions. Their mental status, in-
cluding the anxiety and depression scores, did not differ
significantly between the groups. We have shown that
those patients who were suffering from a chronic kidney
failure had decreased physical function scores, whereas
the underlying liver disease had no impact on the results
of both questionnaires.
Our group has previously reported good HRQoL and
mental status scores among LT recipients when com-
pared to the patients on the LT waiting list and the gen-
eral population, respectively [7, 8]. In the current
literature, there are numerous studies analysing the psy-
chosocial factors in LT recipients [7, 15, 17, 18].
With regards to the results of the HADS survey, the
anxiety and depression scores were lower than those in
previous studies [7, 23, 24]. We have previously shown
that the mental status (anxiety) of patients who under-
went an LT was affected when compared to the general
population [16]. Although not statistically significant, pa-
tients from the Re-LT group tended to have higher anx-
iety and depression scores, so there seems to be a
further decrease in mental status after Re-LT. Since
there are a few studies examining HRQoL but not men-
tal status after Re-LT [9, 12, 13], the interpretation of
our data in a greater context is difficult and speculative.
Re-LT is associated with a higher rate of chronic graft
failure [25]. Patients on the liver transplantation waiting
list have who suffer from chronic liver disease were
found to have higher levels of anxiety and depression
when compared to LT recipients [8]. Some HRQoL stud-
ies include Re-LT patients [9, 12–14]. However, in these
examinations, there is no thorough analysis of this
Fig. 1 SF-36 (a) and HADS (b) of the patient group that was interviewed both in 2011 and 2013 (n = 33). PF = physical functioning, RP = role-physical,
BP = bodily pain, GH = general health perceptions, VIT = Vitality, SF = social functioning, RE = role-emotional, MH = mental health, PCS = physical
component summary, MCS = mental component summary
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subgroup. Braun and colleagues mention a significant
loss of HRQoL among Re-LT patients without further
specification [13]. These findings are in line with our re-
sults. Although there is a considerable number of Re-LT
patients each year, this patient group is completely un-
derrepresented in HRQoL analyses. In most cases, a
graft loss is due to a primary nonfunction or vascular
thrombosis. About 8% of all LT recipients need to
undergo a retransplantation [26, 27]. Clinical data has
shown that both patient [26, 28, 29] and graft survival
[2] are significantly reduced in Re-LT patients when
compared to primary LT recipients. Re-LT is associated
Table 1 Patient characteristics
Re-LT LT
n (%)/mean n (%)/mean p
Gender 1.000
Male 7 (46.7%) 28 (46.7%)
Female 8 (53.3%) 32 (53.3%)
Total 15 (100%) 60 (100%)
Age (years) 53.6 (SD = 8.4) 53.5 (SD = 8.8) 0.958
<55 years 8 (53.3%) 32 (53.3%) 1.000
≥55 years 7 (46.7%) 28 (46.7%)
Underlying disease 0.159
Alcoholic liver cirrhosis 3 (20.0%) 31 (51.7%)
Cryptoenic liver cirrhosis 2 (13.3%) 5 (8.3%)
Cholestatic bile duct diseases 2 (13.3%) 5 (8.3%)
Viral hepatitis 3 (20.0%) 2 (3.3%)
Acute liver failure 1 (6.7%) 7 (11.7%)
Autoimmune hepatitis 1 (6.7%) 3 (5.0%)
Others 3 (20.0%) 7 (11.7%)
Comorbidities
Arterial hypertension 9 (60.0%) 40 (66.7%) 0.763
Diabetes mellitus 6 (40.0%) 21 (35.0%) 0.768
Chronic kidney failure 12 (80.0%) 32 (53.3%) 0.081
Time since transplantation 0.594
<5 years 10 (66.7%) 40 (66.7%)
5–10 years 4 (26.7%) 11 (18.3%)
>10 years 1 (6.7%) 9 (15.0%)
Committed relationship 0.448
Yes 10 (66.7%) 32 (53.3%)
No 1 (6.7%) 12 (20.0%)
No answer 4 (26.7%) 16 (26.7%)
Family status 0.814
Unmarried 1 (6.7%) 7 (11.7%)
Married 8 (53.3%) 31 (51.7%)
Divorced 1 (6.7%) 6 (10.0%)
Widowed 1 (6.7%) 1 (1.7%)
No answer 4 (26.7%) 15 (25.0%)
Religious 0.448
Yes 1 (6.7%) 10 (16.7%)
No 10 (66.7%) 35 (58.3%)
No answer 4 (26.7%) 15 (25.0%)
Re-LT Liver retransplantation group, LT Liver transplantation group. Statistical test: Pearson Chi-Square
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with an increased postoperative morbidity, including pri-
mary graft dysfunction, adult respiratory distress syn-
drome, infections, and acute renal failures, when
compared to a primary LT [15]. This might be an ex-
planation for the fact that there was a significant decre-
ment in the HRQoL dimensions of PF, RP, VIT, and RE.
An important aspect is the longevity of an LT, which is
associated with a higher HRQoL [9]. For various rea-
sons, such as the difficulties of redo surgery procedures,
immunological problems after repeated organ transplan-
tations, and a general poor health status at the time of
the retransplantation, long-term graft survival is signifi-
cantly impaired after an Re-LT [26, 30].
Montenevo have analysed a large cohort of Re-LT re-
cipients and found that these patients were more likely
to be on dialysis prior to transplant, hospitalized, in the
intensive care unit, on a ventilator and had higher model
for end-stage liver disease (MELD) while they had, on
the other hand, lower Donor Risk scores when com-
pared to primary LT recipients [6]. The authors state
that higher quality grafts are used inefficiently in a sicker
patient population and propose a more optimal strategy
including restricting their use to patients who obtain a
longer term benefit [6]. Although we have not analyzed
the clinical course of the patients examined in the
present study, the decrement, especially in HRQoL
scores of Re-LT patients compared to primary LT pa-
tients underlines the need for an optimized organ distri-
bution strategy. Our analysis further revealed that those
patients who suffered from chronic kidney disease had
lower PF scores compared to patient who patients who
had not. These findings are in line with the current lit-
erature, HRQoL was found to be decreased in renal pa-
tients in the early stages of disease [31].
The comparison of our results with other studies is
somewhat difficult, since there are no HRQoL studies on
Re-LT patients. Nonetheless, our findings have indicated
that patients who undergo an Re-LT, are at a risk of suf-
fering from psychological disorders, as well as from an
impaired HRQoL. As a consequence, a profound selec-
tion process of patients who are scheduled for an Re-LT
has to be performed. One of the shortcomings is the
cross-sectional design of this study. Additionally, the
number of Re-LT patients was small. Since the response
rate of the postal survey was 40%, there might be some
selection bias which could possibly lead to the fact that
only patients with either a extremely high or low
HRQoL respond to the survey. Moreover, the interpret-
ation of data is limited by the lack of clinical data such
as performance status, the presence of ascites and ic-
terus, and laboratory data since these factors are known
to have an impact on physical status. Furthermore, the
HRQoL data analysed in this examination are from two
different surveys using different assessment methods.
Fig. 2 SF-36 results of both groups. Re-LT = Liver Retransplantation
group, LT = Liver Transplantation group. PF = physical functioning,
RP = role-physical, BP = bodily pain, GH = general health perceptions,
VIT = Vitality, SF = social functioning, RE = role-emotional, MH = mental
health, PCS = physical component summary, MCS = mental component
summary. * Statistically significant
Fig. 3 HADS results for both groups. Re-LT = Liver Retransplantation
group, LT = Liver Transplantation group. * Statistically significant
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Since, it is known that different modes of HRQoL as-
sessments lead to differing results [32]. Also, there is
some potential time effect, since, as far as the group that
was interviewed twice is concerned, only the most recent
surveys (2013) were used for the comparisons. HRQoL
might change over time and with increasing age, so this
is a potential bias to our data. Although there were no
statistically significant differences between the two as-
sessments, these effects cannot completely be excluded.
However, recent studies have only included Re-LT pa-
tients as a part of a bigger study collective without a
closer examination of this subgroup. The present study
is the first study to thoroughly focus on the HRQoL and
the mental status in Re-LT patients. Moreover, we have
established a matched control group, allowing for a good
comparison of the results. Nevertheless, there is an
urgent need for further studies, with larger sample sizes,
in order to draw final conclusions on this topic.
Conclusion
Patients who have to undergo Re-LT procedures are
facing a postoperative impairment, especially with the
physical aspects of a HRQoL. Together with clinical
results from other studies, the findings of the present
examination underline the need for an optimized organ
distribution strategy since not all patients listed for Re-
LT appear to benefit from it.
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